Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthy ExtractsHYEX 59 Equity-to-Asset is 0.69 as of Jun. 2026, which is 283% above its 10-year median of 0.18. GuruFocus rates HYEX with a GF Score™ of 59/100 and a GF Value™ of $1.14 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Healthy Extracts ranks better than 63.46% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Healthy Extracts's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $22.44 Mil. Healthy Extracts's Total Assets for the quarter that ended in Jun. 2026 was $32.61 Mil.
Therefore, Healthy Extracts's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.69.
The historical rank and industry rank for Healthy Extracts's Equity-to-Asset or its related term are showing as below:
HYEX'
s Equity-to-Asset Range Over the Past 10 Years
Min: -41.44 Med: 0.18 Max: 0.97
Current: 0.69
During the past 11 years, the highest Equity to Asset Ratio of Healthy Extracts was 0.97. The lowest was -41.44. And the median was 0.18.
HYEX's Equity-to-Asset is ranked better than 63.46% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs HYEX: 0.69
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Healthy Extracts Equity-to-Asset Related Terms
Healthy Extracts Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Healthy Extracts's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HYEX vs IGPK, CABR, BFRI: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Healthy Extracts's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts (HYEX) has a Equity-to-Asset of 0.69 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Healthy Extracts and its competitors. This is 283% above median its historical median of 0.18. According to the industry distribution chart, Healthy Extracts ranks #368 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 36.5%.
Is Healthy Extracts' Equity-to-Asset too high?
Healthy Extracts' current Equity-to-Asset of 0.69 is 283% above median its 10-year median of 0.18. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Healthy Extracts' value of 0.69 is 15% above this industry median. Based on the distribution chart, Healthy Extracts ranks #368 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Healthy Extracts has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' Equity-to-Asset compare to IGPK and CABR?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #368 out of 1007 companies for Equity-to-Asset. This puts Healthy Extracts in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Healthy Extracts' value of 0.69 is 15% above this benchmark. While the company's 10-year median is 0.18 vs. the industry median of 0.60, Healthy Extracts has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthy Extracts's current Equity-to-Asset of 0.69 is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Healthy Extracts and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthy Extracts's current Equity-to-Asset is 0.69, which is 283% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Fairly Valued. The stock's GF Value™ is $1.14, compared to a current price of $1.20 — trading 5.3% above its estimated fair value. The current Equity-to-Asset is 0.69, which is 283% above median its 10-year median of 0.18 and 15% above the Drug Manufacturers industry median of 0.60. Healthy Extracts' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current Equity-to-Asset is 0.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be overvalued.
The current stock price of $1.20 is trading 5.3% above its estimated GF Value™ of $1.14.
GuruFocus considers Healthy Extracts to be Fairly Valued.
Key valuation signals for HYEX:
Equity-to-Asset: 0.69 (283% above median its 10-year median of 0.18)
GF Value™: $1.14 vs. price of $1.20 (5.3% above fair value)
Industry Position: 15% above the Drug Manufacturers median (#368 of 1007)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
59GF Score
Get the complete analysis for HYEX
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
